Survey: What Will You Do About Rosiglitazone (Avandia)?

Article

Take this MedPage Today survey.

On Monday, a special FDA advisory panel recommended that rosiglitazone (Avandia) stay on the market, despite an acknowledged increase in ischemic heart risks for type 2 diabetes patients. A meta-analysis published this spring linked the drug to a 43% increase in risk of myocardial infarction.

Recent Videos
"Vaccination is More of a Marathon than a Sprint"
Vaccines are for Kids, Booster Fatigue, and Other Obstacles to Adult Immunization
Related Content
Majority of Americans (8 in 10) Support Routine Childhood Vaccine Requirements, According to New Harvard Poll / image credit ©Sula Nualpradid/stock.adobe.com

Majority of Americans (8 in 10) Support Routine Childhood Vaccine Requirements, According to New Harvard Poll

Grace Halsey
July 1st 2025
Article

As authorities record data on the largest US measles outbreak in decades, 79% of Americans support school vaccine mandates for children, an encouraging result.

The Weekly Dose: Cannabis, Contraceptives, and Advances in Alzheimer Disease and Gonorrhea Treatment

The Weekly Dose: Cannabis, Contraceptives, and Advances in Alzheimer Disease and Gonorrhea Treatment

Sydney Jennings
June 11th 2025
Podcast

Clinical insights on cannabis and dementia, hormonal contraceptives and postpartum depression, the FDA-approved blood test for Alzheimer disease, more.

SDOH May Affect Use of Menopausal Hormone Therapy: Daily Dose / image credit: ©New Africa/AdobeStock

SDOH May Affect Use of Menopausal Hormone Therapy: Daily Dose

Sydney Jennings
July 1st 2025
Article

Your daily dose of the clinical news you may have missed.

The Weekly Dose: Advancements in Colonoscopy, AI for Mammography, and Telemedicine Antibiotic Stewardship

The Weekly Dose: Advancements in Colonoscopy, AI for Mammography, and Telemedicine Antibiotic Stewardship

Sydney Jennings
June 4th 2025
Podcast

Discover the latest breakthroughs in clinical research, from at-home cancer screening to AI advancements in mammography, shaping future healthcare practices.

Moderna's mRNA-1010 Influenza Vaccine Proves Superior Efficacy in Pivotal Late-Stage Trial / image credit ©digitalskillet1/stock.adobe.com

Moderna's mRNA-1010 Flu Vaccine Proves Superior Efficacy in Pivotal Late-Stage Trial

Grace Halsey
June 30th 2025
Article

The vaccine showed superior relative vaccine efficacy that was 26.6% higher than a licensed standard-dose influenza vaccine, Moderna reported.

Survey Finds People with Atopic Dermatitis Want Better Symptom Relief: Daily Dose / image credit: ©New Africa/AdobeStock

Survey Finds People with Atopic Dermatitis Want Better Symptom Relief: Daily Dose

Sydney Jennings
June 30th 2025
Article

Your daily dose of the clinical news you may have missed.

© 2025 MJH Life Sciences

All rights reserved.